These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37164772)

  • 41. [New drug approval: Tebentafusp for treatment of metastatic uveal melanoma HLA A*02:01-positive patients].
    Gaillard A; Matet A; Rodrigues M
    Bull Cancer; 2023 Jan; 110(1):9-10. PubMed ID: 36357199
    [No Abstract]   [Full Text] [Related]  

  • 42. [Palliative care for children in onco-hematology: Role of a specific home-care team].
    Bertrand A; Marcault-Derouard A; Devaux Y; Bertrand Y; Bergeron C; Veyet V; Cervos M; Filion S; Goy F; Schell M
    Bull Cancer; 2018 Sep; 105(9):771-779. PubMed ID: 30251628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [How to choose the optimal therapy? New issues in the treatment of metastatic melanoma].
    Oláh J; Gyulai R
    Magy Onkol; 2016 Mar; 60(1):17-21. PubMed ID: 26934346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Palliative care medical consultation in a hematology department. Feedback and critical reflection on a year of practice].
    Prod'homme C
    Bull Cancer; 2020 Nov; 107(11):1118-1128. PubMed ID: 33059871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hoping for the best and preparing for the worst: a forgotten maxim in the immunotherapy era?
    LeBlanc TW
    Palliat Med; 2020 Dec; 34(10):1289-1290. PubMed ID: 32912076
    [No Abstract]   [Full Text] [Related]  

  • 46. [Adjuvant and palliative therapy of melanoma. Current status].
    Tilgen W
    Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Extending the palliative approach across the French health system].
    Mino JC
    Soins; 2015 Nov; (800):22-4. PubMed ID: 26567066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma.
    Kamminga NCW; van der Veldt AAM; Joosen MCW; de Joode K; Joosse A; Grünhagen DJ; Nijsten TEC; Wakkee M; Lugtenberg M
    Br J Dermatol; 2022 Sep; 187(3):381-391. PubMed ID: 35596713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Innovative therapies for metastatic melanoma in elderly patients].
    Du-Thanh A; Lesage C; Ferreira E; Dereure O; Guillot B
    Ann Dermatol Venereol; 2015 Oct; 142(10):549-56. PubMed ID: 25986740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Palliative care day hospital and nursing coordination].
    Teillet F
    Soins; 2015 Nov; (800):39-40. PubMed ID: 26567073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Shared medical decision-making at the end of life, the role of the home health nurse].
    Collas A; Brauer M; Roucoules B
    Soins; 2019 Mar; 64(833):41-43. PubMed ID: 30879630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [End-of-life and advance healthcare directives].
    Auger S; Colin M; Gelin Y; Perret J; Plassard C
    Rev Infirm; 2019 Nov; 68(255):34-36. PubMed ID: 31757328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Organising and supporting the end of life when faced with a refusal of care].
    Rautureau P
    Rev Infirm; 2018 Apr; 67(240):24-26. PubMed ID: 29609786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Another way to care for cancer].
    de Chassey L; Marin I; Piazza S; Laplanche V; Gauthier R; Clochez T
    Rev Infirm; 2018; 67(243):34-35. PubMed ID: 30262010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastasectomy and active specific immunotherapy for a large single melanoma metastasis.
    Baars A; van Riel JM; Cuesta MA; Jaspars EH; Pinedo HM; van den Eertwegh AJ
    Hepatogastroenterology; 2002; 49(45):691-3. PubMed ID: 12063971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?
    Hurst R; White DE; Heiss J; Lee DS; Rosenberg SA; Schwartzentruber DJ
    J Immunother; 1999 Jul; 22(4):356-62. PubMed ID: 10404437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability.
    Lacey J; Lomax AJ; McNeil C; Marthick M; Levy D; Kao S; Nielsen T; Dhillon HM
    Support Care Cancer; 2019 Apr; 27(4):1497-1507. PubMed ID: 30392112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st-line BRAF-targeted therapy.
    Jones J; Lucey R; Corrie P
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):595-604. PubMed ID: 36114599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The decision to withdraw specific treatments in oncology].
    Laouisset C; Waechter L; Rossi A; Loureiro É; Bahyou S; Marchal T; Burnod A; Bouleuc C
    Soins; 2019 Mar; 64(833):38-40. PubMed ID: 30879629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [End-of-life in specialized medical pediatrics department: A French national survey].
    Ravanello A; Desguerre I; Frache S; Hubert P; Orbach D; Aubry R
    Arch Pediatr; 2017 Mar; 24(3):231-240. PubMed ID: 28131553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.